Literature DB >> 8103361

Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods.

B Ohlsson1, K G Tranberg, C Lundstedt, H Ekberg, E Hederström.   

Abstract

OBJECTIVE: To assess and compare the accuracy of imaging methods (ultrasonography (US), computed tomography (CT), angiography, arterially enhanced CT with computed tomographic arterial portography (CTA)), biochemical analyses, and surgical assessment during the operation, in detecting the presence of absence of hepatic metastases in patients with colorectal cancer.
DESIGN: Open study.
SETTING: University of Lund, Sweden.
SUBJECTS: 71 consecutive patients without clinical evidence of liver metastases at the time of the operation for removal of the primary tumour.
INTERVENTIONS: Regular biochemical tests for five to seven years, and CT and US one year after operation in all patients without confirmed metastases. MAIN OUTCOME MEASURES: Presence or absence of hepatic metastases.
RESULTS: Accuracy of surgical assessment, angiography, US, CT and CTA was 90, 77, 80, 82 and 83%, respectively, and corresponding predictive values of a negative test were 87, 75, 77, 80 and 84%. Measurement of bilirubin concentration and hepatic enzyme activities were not helpful, and that of carcinoembryonic antigen had an accuracy of only 70%. Accuracy and predictive values were not improved by combining tests.
CONCLUSION: The accuracy of US, CT or CTA was not good enough to merit routine use before operations for colorectal cancer. They are potentially valuable for monitoring progress at follow up, but this remains to be confirmed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103361

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  14 in total

1.  LIVER RESECTION FOR METASTASES FROM COLORECTAL CANCER.

Authors:  H G Mukhopadhyay; L S Vohra; A K Sharma; R Solanki; P S Reddy; G S Chopra; P Subhas
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 2.  Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue.

Authors:  T Albrecht; A Oldenburg; J Hohmann; J Skrok; C W Hoffmann; S Schettler; K J Wolf
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 5.315

Review 3.  What is the current situation in liver imaging?

Authors:  M M Uggowitzer
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 5.315

Review 4.  [Modern imaging for liver metastases from colorectal tumors].

Authors:  J Gaa; H Wieder; M Schwaiger; E J Rummeny
Journal:  Chirurg       Date:  2005-06       Impact factor: 0.955

5.  [Transcutaneous ultrasound].

Authors:  M Hünerbein; S S Chopra; P M Schlag
Journal:  Chirurg       Date:  2007-05       Impact factor: 0.955

Review 6.  [Radiological diagnosis of primary hepatic malignancy].

Authors:  Benjamin Henninger; Johannes Petersen; Werner Jaschke
Journal:  Wien Med Wochenschr       Date:  2013-02-08

7.  Management of hepatic metastases from colorectal cancer.

Authors:  Ketan R Sheth; Bryan M Clary
Journal:  Clin Colon Rectal Surg       Date:  2005-08

8.  Detection of hepatic VX2 tumors in rabbits: comparison of conventional US and phase-inversion harmonic US during the liver-specific late phase of contrast enhancement.

Authors:  Jeong Min Lee; Ji Hyun Youk; Young Hwan Lee; Young Kon Kim; Chong Soo Kim; Chun Ai Li
Journal:  Korean J Radiol       Date:  2003 Apr-Jun       Impact factor: 3.500

Review 9.  Non-invasive diagnostic imaging of colorectal liver metastases.

Authors:  Pier Paolo Mainenti; Federica Romano; Laura Pizzuti; Sabrina Segreto; Giovanni Storto; Lorenzo Mannelli; Massimo Imbriaco; Luigi Camera; Simone Maurea
Journal:  World J Radiol       Date:  2015-07-28

10.  Monitoring carcinoembryonic antigen in colorectal cancer: is it still useful?

Authors:  G Li Destri; S Greco; C Rinzivillo; A Racalbuto; R Curreri; A Di Cataldo
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.